Naka Maiko

Kanamori Akiyasu, Naka Maiko, Akashi Azusa, Fujihara Masashi, Yamada Yuko, Nakamura Makoto

Macular OCT grid-pattern cluster analysis showed superior sensitivity for detecting early and preperimetric glaucoma compared to average thickness, offering a more reliable diagnostic approach.

Naka Maiko, Kanamori Akiyasu, Negi Akira, Nakamura Makoto

Elevated IOP in rats reduced AQP9 in the optic nerve head and retina. This suggests AQP9 dysregulation, potentially impacting metabolite transfer, contributes to glaucomatous optic neuropathy.

Kanamori Akiyasu, Naka Maiko, Fukuda Masahide, Nakamura Makoto, Negi Akira

Tafluprost, a glaucoma drug, was found to directly protect retinal ganglion cells from apoptosis in lab and animal models. This suggests it may offer neuroprotection beyond pressure lowering in glaucoma.

Naka Maiko, Kanamori Akiyasu, Tatsumi Yasuko, Fujioka Miyuki, Nagai-Kusuhara Azusa, Nakamura Makoto et al.

This study compared visual field indices (MD, AGIS, CIGTS) with structural parameters in glaucoma. It found MD was comparable to other indices for assessing functional damage, particularly in advanced stages, suggesting MD remains useful clinically.